Genetic Testing Market Envisions a Bright Future: Expecting a 10% CAGR Over the Forecast PeriodPosted by Prathamesh on January 24th, 2024 Genetic testing is a type of medical examination that detects changes to genes, chromosomes, or proteins. Results can confirm or rule out suspected genetic diseases, assisting in determining the risk of acquiring or transmitting genetic illnesses. There are several sorts of genetic tests.:
To learn more about the research, fill out a quick inquiry for a sample report: https://meditechinsights.com/genetic-testing-market/request-sample/ Genetic testing's critical role in disease identification drives genetic testing market growth. Genetic testing, especially prenatal and neonatal screening, is critical in detecting disorders including Thalassemia, Down syndrome, and cystic fibrosis. The rising incidence of genetic illnesses is predicted to drive up global demand for genetic diagnostics. For example, according to UN figures issued on World Down Syndrome Day (March 21, 2022), around 3,000 to 5,000 infants are born with Down Syndrome each year throughout the world. According to the Cystic Fibrosis Foundation Patient Registry, around 40,000 children and adults in the United States have cystic fibrosis, with about 1,000 new cases identified each year. Additionally, the Indian Academy of Thalassemia in 2021 reported that around 15,000 children are born with Thalassemia in India, contributing to approximately 10% of global Thalassemia cases in children. Growing interest in early and preventive care is driving demand in the genetic testing market The desire for early and preventative care is a major driver of the genetic testing business in the United States. The rising cost implications associated with illness treatment have led healthcare providers and regulatory agencies to prioritize early detection and health risk assessment. According to the Centers for Disease Control and Prevention (CDC), chronic illnesses, particularly cardiovascular problems, account for an estimated USD 320 billion in direct and indirect healthcare costs in the United States each year. Genetic testing is becoming important in detecting and avoiding major disease problems before they worsen. As a result, these tests have become fundamental in preventative care, with the majority of private healthcare payers integrating.The market is further fueled by the growing adoption of these testing procedures for rare genetic disorders, supported by increased coverage and favorable reimbursement policies for preventive genetic testing. Competitive Landscape analysis of thegenetic testing market Some of the key players operating in the market include Abbott Laboratories, Danaher Corporation, Thermos Fisher Scientific, Hoffmann-La Roche, Qiagen, Illumina, Myriad Genetics, Bio-Rad Laboratories, DiaSorin/Luminex Corporation, CircleDNA, tellmeGen, 23andMe, AncestryDNA, Mapmygenome, Color Health, MyHeritage, among others. Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the genetic testing market To improve their market position, extend their services, and broaden their client base, players in this industry use both organic and inorganic development tactics, such as releasing new goods and acquiring related businesses. For instance,
The Genetic Testing Market is expected to grow further in the coming years as a result of increased adoption of next-generation sequencing, rising disposable income, technological advancements and the availability of new tests, and aggressive organic and inorganic growth strategies implemented by the players. Get Detailed Insights on the Genetic testing market @ https://meditechinsights.com/genetic-testing-market/ Like it? Share it!More by this author |